RxDoctor Payments Data

William Short, MD

Family Medicine · Abilene, KSNPI 1841300340

Payments from drug & device makers

$1,676in general payments, 2019–2025

Across 102 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$264
  • Pfizer$242
  • Amgen$183
  • Lilly USA, LLC$122
  • Novartis$110
  • AbbVie$81
  • plus $672 from 22 others

What the payments were for

  • Food & beverage$1,676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,676 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$43,750
Medicare patients
95
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$59,633
OzempicSemaglutide58$55,520
XareltoRivaroxaban69$49,099
Tresiba Flextouch U-200Insulin Degludec15$9,193
FarxigaDapagliflozin Propanediol12$6,291
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$6,267
Tresiba Flextouch U-100Insulin Degludec12$5,860
Combivent RespimatIpratropium/Albuterol Sulfate13$5,687
MyrbetriqMirabegron12$5,544
Spiriva HandihalerTiotropium Bromide11$5,534
SymbicortBudesonide/Formoterol Fumarate11$2,488
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen137$2,405
Tolterodine Tartrate ErTolterodine Tartrate13$2,245
Atorvastatin Calcium394$2,182
Pregabalin47$1,945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$242$59,633117 claims
Novo NordiskOzempic$264$55,52058 claims
Johnson & JohnsonXarelto$12$49,09969 claims
AstraZenecaFarxiga, Symbicort$23$8,77923 claims
Boehringer IngelheimCombivent Respimat$17$5,68713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Abilene

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →